SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-08-005691
Filing Date
2008-05-01
Accepted
2008-05-01 16:46:56
Documents
4
Effectiveness Date
2008-05-01

Document Format Files

Seq Description Document Type Size
1 DEF14A a2185340zdefa14a.htm DEFA14A 170439
2 G185277.JPG g185277.jpg GRAPHIC 6366
3 G1012795.JPG g1012795.jpg GRAPHIC 2986
4 G202915.JPG g202915.jpg GRAPHIC 8021
  Complete submission text file 0001047469-08-005691.txt   196185
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 08795323
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1